Phase 1Status unknown
This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.
A Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of Fixed Dose Combination of DW6014 and Loose Combination of Each Component in Healthy Adult Volunteers in Fed Condition
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd. (Industry)
- Enrolment
- 30 planned
- Conditions
- DW6014
- Interventions
- DW6014
- Ages
- adults, older adults
- Registry
- NCT05823883
Full record on ClinicalTrials.gov
From the registry
This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK) after administration of DW6014 and each component in healthy adult volunteers in fed condition.
Primary outcomes
- AUC0-t
- Cmax
History
Study completion
Primary completion
Started
Last registry update
Registered